Healthcare information technology providers Allscripts (NASDAQ:MDRX) and Eclipsys (ECLP) said today they have made a definitive agreement to merge in an all-stock transaction valued at about $1.3 billion.
Eclipsys shareholders will receive 1.2 shares of Allscripts for each Eclipsys share owned, a 19% premium over the June 8 closing price.
The companies said that the merged company will have a client base of 180,000 physicians, 1,500 hospitals, and 10,000 nursing homes, and will have the unique ability to deliver a single patient record and a seamless patient experience in terms of clinical, financial, connectivity and information solutions.
The boards of both companies have approved the deal, although it is still subject to approval by shareholders of both companies.
The transaction is also subject to a secondary offering of Allscripts shares owned by its majority shareholder, Misys.
The transaction is expected to close within six months.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.